FDA Amends Public Meeting Notice of Science Board Advisory Committee

Summary

The Food and Drug Administration (FDA) is updating the notice for a public meeting of the Science Board to the Food and Drug Administration Advisory Committee, primarily due to changes in the meeting agenda, which will now include an open public hearing and open committee discussion, and will be open to the public.